Annual CFF:
-$4.19B-$2.43B(-138.38%)Summary
- As of today, TAK annual cash from financing is -$4.19 billion, with the most recent change of -$2.43 billion (-138.38%) on March 31, 2025.
- During the last 3 years, TAK annual cash from financing has risen by +$4.37 billion (+51.08%).
- TAK annual cash from financing is now -115.58% below its all-time high of $26.88 billion, reached on March 31, 2019.
Performance
TAK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$168.59M+$1.54B(+112.29%)Summary
- As of today, TAK quarterly cash from financing is $168.59 million, with the most recent change of +$1.54 billion (+112.29%) on September 1, 2025.
- Over the past year, TAK quarterly cash from financing has increased by +$697.87 million (+131.85%).
- TAK quarterly cash from financing is now -98.81% below its all-time high of $14.22 billion, reached on March 31, 2019.
Performance
TAK Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$6.98B+$697.87M(+9.09%)Summary
- As of today, TAK TTM cash from financing is -$6.98 billion, with the most recent change of +$697.87 million (+9.09%) on September 1, 2025.
- Over the past year, TAK TTM cash from financing has dropped by -$7.87 billion (-880.55%).
- TAK TTM cash from financing is now -125.96% below its all-time high of $26.89 billion, reached on March 31, 2019.
Performance
TAK TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TAK Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -138.4% | +131.8% | -880.5% |
| 3Y3 Years | +51.1% | +249.8% | -49.3% |
| 5Y5 Years | +48.1% | +108.6% | -53.4% |
TAK Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -138.4% | +51.1% | -92.1% | +104.2% | -880.5% | +9.1% |
| 5Y | 5-Year | -138.4% | +54.7% | -92.1% | +104.2% | -880.5% | +38.7% |
| All-Time | All-Time | -115.6% | +54.7% | -98.8% | +103.0% | -126.0% | +38.7% |
TAK Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $168.59M(+112.3%) | -$6.98B(+9.1%) |
| Jun 2025 | - | -$1.37B(+20.6%) | -$7.68B(-83.8%) |
| Mar 2025 | -$4.19B(-138.4%) | -$1.73B(+57.4%) | -$4.18B(-54.3%) |
| Dec 2024 | - | -$4.05B(-665.1%) | -$2.71B(-402.7%) |
| Sep 2024 | - | -$529.28M(-124.9%) | $894.22M(+37.3%) |
| Jun 2024 | - | $2.13B(+926.1%) | $651.27M(+137.1%) |
| Mar 2024 | -$1.76B(+60.4%) | -$257.80M(+42.5%) | -$1.75B(-17.8%) |
| Dec 2023 | - | -$448.27M(+42.0%) | -$1.49B(+61.8%) |
| Sep 2023 | - | -$772.23M(-179.8%) | -$3.90B(-20.3%) |
| Jun 2023 | - | -$276.03M(-3793.3%) | -$3.24B(+27.2%) |
| Mar 2023 | -$4.43B(+48.2%) | $7.47M(+100.3%) | -$4.45B(+30.1%) |
| Dec 2022 | - | -$2.86B(-2441.1%) | -$6.37B(-36.2%) |
| Sep 2022 | - | -$112.57M(+92.4%) | -$4.68B(+28.4%) |
| Jun 2022 | - | -$1.49B(+22.1%) | -$6.53B(+24.0%) |
| Mar 2022 | -$8.56B(+7.4%) | -$1.91B(-63.0%) | -$8.59B(+14.5%) |
| Dec 2021 | - | -$1.17B(+40.6%) | -$10.05B(+11.8%) |
| Sep 2021 | - | -$1.97B(+44.4%) | -$11.38B(-0.1%) |
| Jun 2021 | - | -$3.55B(-5.5%) | -$11.37B(-21.8%) |
| Mar 2021 | -$9.25B(-14.5%) | -$3.36B(-34.0%) | -$9.34B(-32.9%) |
| Dec 2020 | - | -$2.51B(-28.3%) | -$7.03B(-54.5%) |
| Sep 2020 | - | -$1.95B(-29.3%) | -$4.55B(+44.6%) |
| Jun 2020 | - | -$1.51B(-43.6%) | -$8.21B(-2.2%) |
| Mar 2020 | -$8.08B(-130.0%) | -$1.05B(-3390.4%) | -$8.03B(-210.9%) |
| Dec 2019 | - | -$30.16M(+99.5%) | $7.24B(-65.2%) |
| Sep 2019 | - | -$5.62B(-321.2%) | $20.78B(-20.9%) |
| Jun 2019 | - | -$1.33B(-109.4%) | $26.28B(-2.2%) |
| Mar 2019 | $26.88B(+1037.4%) | $14.22B(+5.3%) | $26.89B(+137.1%) |
| Dec 2018 | - | $13.51B(>+9900.0%) | $11.34B(+512.1%) |
| Sep 2018 | - | -$110.57M(+84.9%) | -$2.75B(+1.9%) |
| Jun 2018 | - | -$730.39M(+45.0%) | -$2.80B(+1.6%) |
| Mar 2018 | -$2.87B(-204.6%) | -$1.33B(-128.9%) | -$2.85B(-436.2%) |
| Dec 2017 | - | -$580.75M(-255.7%) | $847.64M(+5.7%) |
| Sep 2017 | - | -$163.27M(+79.0%) | $802.07M(-9.2%) |
| Jun 2017 | - | -$776.79M(-132.8%) | $882.92M(-67.4%) |
| Mar 2017 | $2.74B(+374.5%) | $2.37B(+478.2%) | $2.71B(+313.2%) |
| Dec 2016 | - | -$626.31M(-659.8%) | $656.09M(-12.8%) |
| Sep 2016 | - | -$82.43M(-107.8%) | $752.62M(-0.9%) |
| Jun 2016 | - | $1.05B(+234.9%) | $759.31M(+175.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$998.88M(+61.5%) | $313.81M(+159.2%) | -$1.00B(+58.6%) |
| Dec 2015 | - | -$529.78M(-599.4%) | -$2.42B(+1.2%) |
| Sep 2015 | - | -$75.74M(+89.3%) | -$2.45B(+6.4%) |
| Jun 2015 | - | -$708.97M(+35.7%) | -$2.62B(+2.3%) |
| Mar 2015 | -$2.59B(-355.9%) | -$1.10B(-97.4%) | -$2.68B(-70.1%) |
| Dec 2014 | - | -$558.99M(-128.7%) | -$1.57B(-55.1%) |
| Sep 2014 | - | -$244.44M(+68.3%) | -$1.01B(-31.7%) |
| Jun 2014 | - | -$770.10M(-495.6%) | -$770.10M(+55.4%) |
| Mar 2014 | $1.01B(+155.2%) | - | - |
| Mar 2013 | -$1.84B(-136.8%) | - | - |
| Mar 2012 | $4.99B(+391.4%) | - | - |
| Mar 2011 | -$1.71B(-7.3%) | -$129.30M(+83.1%) | -$1.73B(+0.2%) |
| Dec 2010 | - | -$765.37M(-475.0%) | -$1.73B(-3.9%) |
| Sep 2010 | - | -$133.11M(+81.0%) | -$1.66B(-1.8%) |
| Jun 2010 | - | -$699.06M(-429.4%) | -$1.63B(-1.8%) |
| Mar 2010 | -$1.59B(+62.3%) | -$132.06M(+81.1%) | -$1.61B(-9.0%) |
| Dec 2009 | - | -$699.81M(-574.6%) | -$1.47B(-90.4%) |
| Sep 2009 | - | -$103.73M(+84.5%) | -$773.86M(-15.5%) |
| Jun 2009 | - | -$670.12M | -$670.12M |
| Mar 2009 | -$4.23B(-84.6%) | - | - |
| Mar 2008 | -$2.29B(+15.1%) | - | - |
| Mar 2007 | -$2.70B(-242.6%) | - | - |
| Mar 2006 | -$788.85M(-14.7%) | - | - |
| Mar 2005 | -$687.62M(-30.9%) | - | - |
| Mar 2004 | -$525.17M(-8.5%) | - | - |
| Mar 2003 | -$483.93M(-14.8%) | - | - |
| Mar 2002 | -$421.40M(-11.2%) | - | - |
| Mar 2001 | -$378.99M(-51.2%) | - | - |
| Mar 2000 | -$250.60M(-39.2%) | - | - |
| Mar 1999 | -$180.07M(-12.7%) | - | - |
| Mar 1998 | -$159.73M(-18.6%) | - | - |
| Mar 1997 | -$134.69M(+16.4%) | - | - |
| Mar 1996 | -$161.04M(+40.9%) | - | - |
| Mar 1995 | -$272.59M(-100.6%) | - | - |
| Mar 1994 | -$135.89M(-83.5%) | - | - |
| Mar 1993 | -$74.07M(+18.5%) | - | - |
| Mar 1992 | -$90.92M(-16.4%) | - | - |
| Mar 1991 | -$78.11M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cash from financing?
- What is the all-time high annual cash from financing for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual cash from financing year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly cash from financing year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cash from financing?
- What is the all-time high TTM cash from financing for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM cash from financing year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cash from financing?
The current annual cash from financing of TAK is -$4.19B
What is the all-time high annual cash from financing for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cash from financing is $26.88B
What is Takeda Pharmaceutical Company Limited annual cash from financing year-on-year change?
Over the past year, TAK annual cash from financing has changed by -$2.43B (-138.38%)
What is Takeda Pharmaceutical Company Limited quarterly cash from financing?
The current quarterly cash from financing of TAK is $168.59M
What is the all-time high quarterly cash from financing for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cash from financing is $14.22B
What is Takeda Pharmaceutical Company Limited quarterly cash from financing year-on-year change?
Over the past year, TAK quarterly cash from financing has changed by +$697.87M (+131.85%)
What is Takeda Pharmaceutical Company Limited TTM cash from financing?
The current TTM cash from financing of TAK is -$6.98B
What is the all-time high TTM cash from financing for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cash from financing is $26.89B
What is Takeda Pharmaceutical Company Limited TTM cash from financing year-on-year change?
Over the past year, TAK TTM cash from financing has changed by -$7.87B (-880.55%)